Stereotaxis and Abbott Announce Global Collaboration Combining Leading Mapping and Robotic Technologies to Improve Treatment of Abnormal Heart Rhythms
Abbott is integrating it’s EnSite X mapping system with Stereotaxis’s robotic surgical system
Stay updated with breaking news from Ensitex System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott is integrating it’s EnSite X mapping system with Stereotaxis’s robotic surgical system
ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott's EnSite X EP System with Stereotaxis' Robotic Magnetic
19.05.2023 - ST. LOUIS, May 19, 2023 (GLOBE NEWSWIRE) - Stereotaxis (NYSE: STXS) today announced a global collaboration with Abbott (NYSE: ABT) to integrate Abbott’s EnSite X EP System with Stereotaxis’ Robotic Magnetic Navigation systems. The combination ...
EnSite X EP mapping system with EnSite Omnipolar Technology provides a 360-degree view of the heart, regardless of catheter orientation
Abbott (NYSE: ABT) today announced it has received clearance from the U.S. Food and Drug Administration for the EnSite™ X EP System with EnSite Omnipolar Technology (OT), a new cardiac mapping platform available in the U.S. and across Europe that is designed to help physicians better treat abnormal heart rhythms ...